PPT-PrEP Training for Providers in Clinical

PrEP Training for Providers in Clinical Settings Version 20 2 Welcome Please sign the registration sheet Please make a name tag for yourself Please ta ke a participant manual notebook and pen. Atlanta, GA. July 23. , . 2010. Shanya Salamaca. RABQSA International. Auditor Workshop. Atlanta, GA. July 22-23, 2010. Background. In accordance with the Supplemental Rule, RABQSA developed processes for the approval of auditors and training providers for the 2009 versions of the AS standards.. in . ARV . based prevention . Edwina Wright MD PhD. Alfred Hospital, Monash University The Burnet Institute. World AIDS Conference,. Melbourne July 2014. Symposium on ARV-based Prevention in Practice: Social and Behavioural Aspects. Clinical trials have shown daily oral . Tenofovir. to effectively prevent HIV acquisition. PrEP must only be prescribed for HIV- patients and patients taking PrEP must have regular tests for HIV and other clinical conditions. . Up in Kenya: . Bridge . to . Scale . Project. IAS Satellite . Session. 25. th. . July . 2017. Dr. Elizabeth . Irungu. Partners Scale up Project, Kenya . Dr. Daniel Were. Jhpiego, Kenya . Background on HIV in Kenya . Bridge . to . Scale . Project. IAS Satellite . Session. 25. th. . July . 2017. Dr. Elizabeth . Irungu. Partners Scale up Project, Kenya . Dr. Daniel Were. Jhpiego, Kenya . Background on HIV in Kenya . Robert M. Grant, M.D., M.P.H. .. IAS 2017, July 2017, Paris. Disclosures. Gilead Sciences donated study medication to US NIH for trials that I have led, including . iPrEx. , . iPrEx. OLE, and HPTN 067.. (Version 2.0). 2. Welcome!. Please sign the registration sheet.. Please make a name tag for yourself.. Please ta. ke a participant . manual, notebook, and pen. . Any component of this document may be reproduced or adapted without prior permission from ICAP, provided that: 1) ICAP is acknowledged; 2) appropriate attribution is given for all changes that are made; and 3) the material is made available free of charge. . (Version 2.0). 2. Welcome!. Please sign the registration sheet.. Please make a name tag for yourself.. Please ta. ke a participant . manual, notebook, and pen. . Any component of this document may be reproduced or adapted without prior permission from ICAP, provided that: 1) ICAP is acknowledged; 2) appropriate attribution is given for all changes that are made; and 3) the material is made available free of charge. . PrEP Considerations for HPX3002/HVTN 706 Susan Buchbinder HVTN Study Chair/San Francisco Site PI PrEP is safe and highly effective against sexual exposures for MSM and TGW 4 Doses/Week has Similar Efficacy to Daily TDF/FTC for MSM Knowledge Just over three-quarters of providers were familiar with oral PrEP, while 23% had not heard of it (Figure 2). The most common sources of information were the national guidelines/policy and other healthcare workers. PrEP to Prevent HIV and Promote Sexual Health www.hivguidelines.org Purpose of the Guideline To provide clinicians throughout NYS with the recommendations needed to successfully start and continue patients on PrEP. U. sers. . W. ho. Test Positive for HIV. Jean-Michel Molina, . MD. University . of . Paris and . Saint-Louis . Hospital, INSERM U944, France. HIV testing and Management in the Era of PrEP. Disclosures. Facilitator Background Materials. Review these slides prior to using these materials. Introduction to Training Materials. These training materials . May need to be modified for use if national guidelines do not align with WHO guidance as of March 2022. Promote Sexual Health. www.hivguidelines.org. MAY 2022. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Increase awareness and knowledge of . PrEP. efficacy among clinicians in NYS..